Codexis Newswire

Comprehensive Real-Time News Feed for Codexis.

Results 1 - 20 of 30 in Codexis

  1. Global Specialty Enzymes Market Outlook, Company Share To 2020: Grand View Research, Inc.Read the original story

    Monday Dec 8 | M2.com

    ... Some leading players operating in the global specialty enzymes market include Advanced Enzyme Technology Ltd., Codexis Inc., Amano Enzyme Inc., Nagase & Co. Ltd., BASF, Roche Holding AG and Sanofi S.A. Request TOC of "Specialty Enzymes Market ...

    Comment?

  2. New Report - Global Specialty Enzymes Market Size, Share To 2020: Grand View Research, Inc.Read the original story

    Sunday Dec 7 | PR-inside.com

    ... Some leading players operating in the global specialty enzymes market include Advanced Enzyme Technology Ltd., Codexis Inc., Amano Enzyme Inc., Nagase & Co. Ltd., BASF, Roche Holding AG and Sanofi S.A. Request TOC of "Specialty Enzymes Market ...

    Comment?

  3. Codexis, Inc. Uses Its Codeevolver Protein Engineering Platform...Read the original story

    Thursday Dec 4 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that it has developed a novel enzyme therapeutic product candidate for the potential treatment of phenylketonuria via oral administration. PKU is an inherited metabolic disorder in which the enzyme that converts the essential amino acid phenylalanine into tyrosine is deficient.

    Comment?

  4. Specialty Enzymes Market - Global Industry Growth, Size, Share,...Read the original story w/Photo

    Thursday Dec 4 | PRWeb

    ... Some leading players operating in the global specialty enzymes market include Advanced Enzyme Technology Ltd., Codexis Inc., Amano Enzyme Inc., Nagase & Co. Ltd., BASF, Roche Holding AG and Sanofi S.A. Grand View Research, Inc. is a U.S. based ...

    Comment?

  5. Codexis, Inc.To Present At The Main Event VII Conference On December 4Read the original story

    Monday Nov 24 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will provide a corporate update at the LD Micro Main Event VII Conference, being held December 2-4, 2014 at The Luxe Hotel in Los Angeles, California. Codexis, Inc. is a leading developer of biocatalysts for pharmaceutical and fine chemical production.

    Comment?

  6. Codexis, Inc. Reports Financial Results For The Third Quarter And...Read the original story

    Nov 5, 2014 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced financial results for the third quarter and nine months ended September 30, 2014. "I am pleased with the solid progress we are making towards our goals for 2014.

    Comment?

  7. Codexis' (CDXS) CEO John Nicols on Q3 2014 Results - Earnings Call TranscriptRead the original story w/Photo

    Nov 4, 2014 | Seeking Alpha

    Good day ladies and gentlemen and welcome to Third Quarter 2014 Codexis Earnings Conference Call. My name is Kim and I will be your operator for today.

    Comment?

  8. Codexis, Inc. Appoints Merck & Co. Global Executive, To Board Of DirectorsRead the original story

    Nov 4, 2014 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the appointment of Pam Cheng to its board of directors. Ms. Cheng is a 17-year veteran of Merck & Co.

    Comment?

  9. Codexis (CDXS) Set to Announce Quarterly Earnings on TuesdayRead the original story

    Oct 31, 2014 | AmericanBankingNews.com

    Codexis is scheduled to issue its quarterly earnings data on Tuesday, November 4th. Parties interested in registering for the company's conference call can do so using this link .

    Comment?

  10. Codexis, Inc. To Report Third Quarter 2014 Financial Results On November 4Read the original story

    Oct 21, 2014 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will report third quarter financial results after the close of market on November 4, followed at 4:30 p.m. Eastern Time by a conference call and audio webcast at www.codexis.com . Codexis, Inc. is a leading developer of biocatalysts for pharmaceutical and fine chemical production.

    Comment?

  11. Codexis, Inc. Appoints Biotechnology Industry Veteran, To Board Of DirectorsRead the original story

    Sep 22, 2014 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the appointment of Kathleen Sereda Glaub to its board of directors. Ms. Glaub's 30-year career in leadership positions with drug development and technology companies will bring strong company-building and business strategy experience to the Codexis board.

    Comment?

  12. Rising Prominence of Sustainable Production Practices Drives the...Read the original story

    Sep 19, 2014 | PRWeb

    ... Ltd., Amano Enzyme Inc., Asahi Kasei Pharma Corporation, BASF SE, BioResource International Inc., Chr. Hansen A/S, Codexis Inc., DuPont Nutrition and Health, Direvo Biotech AG, Enzymatic Deinking Technologies LLC, Hayashibara Company, Novozymes A/S, ...

    Comment?

  13. Codexis Director Acquires $133,200 in StockRead the original story

    Aug 18, 2014 | AmericanBankingNews.com

    Codexis Director Patrick Y. Yang acquired 60,000 shares of Codexis stock in a transaction that occurred on Tuesday, August 12th.

    Comment?

  14. Codexis Director Patrick Y. Yang Buys 60,000 SharesRead the original story

    Aug 14, 2014 | AmericanBankingNews.com

    Codexis Director Patrick Y. Yang bought 60,000 shares of the stock in a transaction that occurred on Tuesday, August 12th.

    Comment?

  15. Egalet Announces Topline Results From Egalet-001; Geron to Assume...Read the original story

    Aug 6, 2014 | Hispanic Business

    Study 067-EG-005 evaluated the area under the curve and the maximum or peak plasma concentration of -001 100 mg versus the same dose of MS Contin in a fasted state in 58 subjects.

    Comment?

  16. Codexis' (CDXS) CEO John Nicols on Q2 2014 Results - Earnings Call TranscriptRead the original story

    Aug 6, 2014 | Seeking Alpha

    Welcome to Codexis second quarter earnings conference call. This call is being webcast live on the investor's section of Codexis' website at codexis.com.

    Comment?

  17. Codexis Reports Financial Results for the Second Quarter of 2014Read the original story

    Aug 6, 2014 | GlobeNewswire

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its financial results for the second quarter ended June 30, 2014.

    Comment?

  18. Gevo CEO Sees Minnesota Biofuels Plant Breaking Even This YearRead the original story

    Aug 1, 2014 | The Washington Post

    ... from plant waste has proven technologically and economically challenging. Alan Shaw, former chief executive of Codexis Inc., the first advanced biofuel company to be publicly traded in the U.S., last year called the industry a "nightmare." He gave ...

    Comment?

  19. Codexis, Inc. To Announce Second Quarter 2014 Financial Results On August 6, 2014Read the original story

    Aug 1, 2014 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will host a live conference call and audio webcast on Wednesday, August 6, 2014 at 4:30 p.m. Eastern Time to discuss its second quarter 2014 financial results.

    Comment?

  20. Gordon Sangster To Join Codexis, Inc. As Senior Vice President & Chief Financial OfficerRead the original story

    Jul 29, 2014 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that Gordon Sangster has agreed to join Codexis as Senior Vice President & Chief Financial Officer.

    Comment?